<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Arbutus Biopharma Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      William H. Collier
    • FOUNDED
      1992
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU
    Kindred Biosciences, Inc.

    Kindred Biosciences, Inc.

    KindredBio is focused on bringing breakthrough human products and innovative new t...

    KindredBio is focused on bringing breakthrough ...

    Filing Type:    PU
    Wuxi Biologics (Cayman) Inc

    Wuxi Biologics (Cayman) Inc

    WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading glo...

    WuXi Biologics (stock code: 2269.HK), a Hong Ko...

    Filing Type:    PU
    Allakos Inc.

    Allakos Inc.

    Allakos is a clinical-stage company developing therapeutic antibodies that selecti...

    Allakos is a clinical-stage company developing ...

    Filing Type:    PU
    Aclaris Therapeutics, Inc.

    Aclaris Therapeutics, Inc.

    Since Aclaris was founded in 2012, our focus has been innovation to help people wi...

    Since Aclaris was founded in 2012, our focus ha...

    Filing Type:    PU
    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    Assembly Biosciences, Inc.

    Assembly Biosciences, Inc.

    Assembly Biosciences is advancing a new class of oral therapeutics for the treatme...

    Assembly Biosciences is advancing a new class o...

    Filing Type:    PU
    Spring Bank Pharmaceuticals, Inc.

    Spring Bank Pharmaceuticals, Inc.

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery...

    Spring Bank is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.